These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 348316)

  • 21. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Frei E
    Cancer; 1977 Dec; 40(6):2792-6. PubMed ID: 589555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
    Fleischer I; Wainstein R; Jovtis S; Colombato LO
    Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
    Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
    Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorouracil, methyl-CCNU and vincristine in cancer of the colon.
    Falkson G; Falkson HC
    Cancer; 1976 Oct; 38(4):1468-70. PubMed ID: 791472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil.
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1603-5. PubMed ID: 361230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
    Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
    Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases.
    Lehane DE; Lane M; Tranum B; Costanzi J; Padilla F
    Cancer Treat Rep; 1977 Aug; 61(5):889-91. PubMed ID: 329982
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
    Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
    Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A; Kolarić K
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.